Indications for TAVI in adults aged 18–60 years (aged 16–60 years)
| Median (IQR) | |
| High surgical risk (EuroSCORE II >6%) | 9 (8–9) |
| Severe liver disease | 8 (7–9) |
| Previous stroke—neurological sequelae and reduced mobility | 8 (8–9) |
| History of cancer with reduced life expectancy | 9 (8–9) |
| Severe frailty | 8 (8–9) |
TAVI, transcatheter aortic valve implantation.